中科微点-全球专利检索

  1. Login
  2. Sign Up

Search Results

11 records (took 0.023 seconds)

    INJECTION SITE PROTECTIVE CAP
    1.
    发明申请
    INJECTION SITE PROTECTIVE CAP 审中-公开
    注射场保护帽

    公开(公告)号：WO1993003702A1

    公开(公告)日：1993-03-04

    申请号：PCT/US1992006909

    申请日：1992-08-17

    Applicant: BAXTER INTERNATIONAL INC.

    Inventor： BAXTER INTERNATIONAL INC. ,  STONIS, Thomas, A. ,  PACKARD, Jeffrey ,  FINLEY, Michael ,  ROLLINS, Richard, A.

    IPC: A61J01/00

    CPC classification number: A61J1/10

    Abstract: A cap (34) for providing a tamper evident cover for sealing a portion of an additive port (14), including an injection site (22), of a container (10). The cap (34) comprising first and second halves (36, 38) hinged together along a first edge (40, 42) of each allowing portions of the halves to move towards and away from each other. An interior (50, 52) is defined by the halves for receiving at least a portion of the port (14) and the injection site (22). Members (54, 56) are provided for securing a second edge of the first half to a second edge of the second half. At least one of the first or second halves (36, 38) includes a member (57) circumscribing an interior thereof for causing at least the injection member to be removed upon the application of a sufficient pulling force when the cap is secured to the additive port.

    Abstract translation: 一种用于提供用于密封包含容器（10）的注入部位（22）的添加剂端口（14）的一部分的防拆封盖的盖（34）。 包括第一和第二半部（36,38）的盖子（34,38）沿着每个的第一边缘（40,42）铰接在一起，允许半部分的部分朝向和远离彼此移动。 内部（50,52）由用于容纳端口（14）和注射部位（22）的至少一部分的一半限定。 构件（54,56）被设置用于将第一半部的第二边缘固定到第二半部的第二边缘。 第一或第二半部（36,38）中的至少一个包括围绕其内部的构件（57），用于当帽被固定到添加剂时至少引入注射构件以施加足够的拉力时被移除 港口。

    DRUG DELIVERY SYSTEM
    2.
    发明申请
    DRUG DELIVERY SYSTEM 审中-公开
    药物递送系统

    公开(公告)号：WO1995001197A1

    公开(公告)日：1995-01-12

    申请号：PCT/US1994003859

    申请日：1994-04-08

    Applicant: BAXTER INTERNATIONAL INC.

    Inventor： BAXTER INTERNATIONAL INC. ,  FOWLES, Thomas, A. ,  ROLLINS, Richard, A. ,  HOEKWATER, Mark, A.

    IPC: A61M05/24

    CPC classification number: A61J1/2089 ,  A61J1/201 ,  A61J1/2013 ,  A61J1/2065 ,  A61M5/1409

    Abstract: An improved drug delivery system and method for reconstituting drugs. The system allows the delivery of a medicament from a drug vial (40) directly into an intravenous line to a patient. The system provides a method and apparatus that insures that the drug vial is properly pierced and the vial is locked into an activated position when it is desired to use same. To this end, a vial retaining member (50) for coupling the vial to a cartridge (12) including a cannula (22) is provided. The retaining member includes a cannula centering member (64) extending from an end thereof.

    Abstract translation: 改进的药物递送系统和重建药物的方法。 该系统允许将药物从药物瓶（40）直接输送到患者的静脉内管线中。 该系统提供了一种方法和装置，其确保药物瓶被适当刺穿，并且当需要使用该小瓶时，将小瓶锁定在激活位置。 为此，提供了用于将小瓶耦合到包括插管（22）的盒（12）的小瓶保持构件（50）。 保持构件包括从其端部延伸的套管对中构件（64）。

    CONTAINER FOR THE CONTROLLED ADMINISTRATION OF A BENEFICIAL AGENT
    3.
    发明申请
    CONTAINER FOR THE CONTROLLED ADMINISTRATION OF A BENEFICIAL AGENT 审中-公开
    控制管理有益代理人的集装箱

    公开(公告)号：WO1993016754A1

    公开(公告)日：1993-09-02

    申请号：PCT/US1993001171

    申请日：1993-02-09

    Applicant: BAXTER INTERNATIONAL INC.

    Inventor： BAXTER INTERNATIONAL INC. ,  BUTTON, Kathryn, M. ,  JEPSON, Steven, C. ,  LAL, Birendra, K. ,  REITZ, Douglas, W. ,  RICHARDSON, James ,  ROLLINS, Richard, A. ,  SOLTYS, Paul, J. ,  DUDAR, Thomas, E.

    IPC: A61M37/00

    CPC classification number: A61M5/1409

    Abstract: A container (30) for housing a beneficial agent (66) that can be removably coupled to a structure (12) defining a fluid flow path. The container (30) comprises a body (32) defining a first (56) and second (58) interior area separated by a wall (60) that terminates at an opening (62) providing fluid communication between the first (56) and second (58) interior area. A cannula (34) is provided that extends from the body (32) for being removably received by the structure (12) defining the fluid path. The cannula (34) including an inlet opening (44) and inlet fluid flow path (36) and an outlet opening (54) and outlet fluid flow path (37). The inlet fluid flow path (36) being in fluid communication with the first interior area (56), and the outlet fluid flow path (37) being in fluid communication with the second interior area (58). The second interior area (58) housing the solid beneficial agent (66) and allows fluid that flows through the inlet fluid flow path to pass by at least a portion of the beneficial agent (66).

    PRE-SLIT INJECTION SITE
    4.
    发明申请
    PRE-SLIT INJECTION SITE 审中-公开
    预先注入网站

    公开(公告)号：WO1991005581A1

    公开(公告)日：1991-05-02

    申请号：PCT/US1990006071

    申请日：1990-10-22

    Applicant: BAXTER INTERNATIONAL INC.

    Inventor： BAXTER INTERNATIONAL INC. ,  DUDAR, Thomas, E. ,  JEPSON, Steven, C. ,  DOBBIE, Robert, P. ,  GRAHAM, Peter, L. ,  FINLEY, Michael, J. ,  ROLLINS, Richard, A.

    IPC: A61M39/04

    CPC classification number: A61M5/162 ,  A61J1/10 ,  A61J1/1406 ,  A61J1/1475 ,  A61J1/201 ,  A61J1/2037 ,  A61J1/2044 ,  A61J1/2055 ,  A61J1/2089 ,  A61J1/2096 ,  A61J2200/10 ,  A61M39/045 ,  A61M39/14 ,  A61M2039/1027 ,  A61M2039/1033 ,  A61M2039/1066 ,  A61M2039/1072 ,  A61M2039/1077 ,  A61M2205/195 ,  A61M2205/197

    Abstract: A pre-slit injection site (710) includes a housing (712) with a flow path (728) therethrough. A first end (714) of the housing (712) carries a pre-slit septum (718). A second end (716) of the housing carries a coupling component (736) to adapt the site to standard vials. The coupling component (736), a vial adapter, includes an adapter spike (752) with openings (758) allowing for the drainage of fluid in the vial through the spike (752) and into the injection site (710). The vial adapter (736) is provided with a skirt housing unit (734, 744) which protects the adapter spike (752) in manufacturing and use. The skirt housing unit (734, 744) also provides features to lockingly engage the adapter (700) with injection site (710) to standard vials, despite dimensional variations in vial closures. Another embodiment of the coupling component (814) is a spike (816) having a barb feature (818) capable of insertion into a standard vial or port and resisting disengagement. A blunt cannula (730) is usable with the injection site (710) combined with the coupling components (736, 814).

    Abstract translation: 预狭缝注射部位（710）包括具有穿过其中的流动路径（728）的壳体（712）。 壳体（712）的第一端（714）承载预狭缝隔垫（718）。 壳体的第二端（716）承载耦合部件（736），以使部位适应标准样品瓶。 联接部件（736），小瓶适配器，包括具有开口（758）的适配器尖钉（752），允许小瓶中的流体通过尖峰（752）排出并进入注射部位（710）。 小瓶适配器（736）设置有裙部壳体单元（734,744），其在制造和使用中保护适配器尖峰（752）。 尽管裙部容纳单元（734,744）还提供了将具有注射部位（710）的适配器（700）锁定到标准瓶中的特征，尽管小瓶封闭件中的尺寸变化。 耦合部件（814）的另一实施例是具有能够插入标准小瓶或端口并抵抗脱离接触的倒钩特征（818）的钉（816）。 钝头插管（730）可与注射部位（710）结合使用，耦合部件（736,814）。

    INJECTION SITE PROTECTIVE CAP
    5.
    发明公开
    INJECTION SITE PROTECTIVE CAP 失效
    CAP FOR注射部位。

    公开(公告)号：EP0553341A1

    公开(公告)日：1993-08-04

    申请号：EP92918580.0

    申请日：1992-08-17

    Applicant: BAXTER INTERNATIONAL INC.

    Inventor： STONIS, Thomas, A. ,  PACKARD, Jeffrey ,  FINLEY, Michael ,  ROLLINS, Richard, A.

    IPC: A61J1

    CPC classification number: A61J1/10

    Abstract: Une coiffe (34) permet de créer un couvercle révélant une tentative d'ouverture, destiné à obturer une partie d'un orifice d'accès (14), y compris un point de ponction (22), d'un conditionnement (10). La coiffe (34) comprend des première et deuxième moitiés (36, 38) articulées l'une à l'autre le long d'un premier bord (40, 42) de chacune, permettant ainsi à des parties de ces deux moitiés de se rapprocher et de s'écarter. Une partie intérieure (50, 52) est définie par les moitiés pour recevoir au moins une partie de l'orifice (14) et le point de ponction (22). Des éléments (54, 56) sont prévus pour assujettir un deuxième bord de la première moitié à un deuxième bord de la deuxième moitié. Au moins l'une des première et deuxième moitiés (36, 38) comporte un élément (57) qui en délimite l'espace intérieur pour provoquer l'enlèvement d'au moins l'élément de ponction lors de l'application d'un effort d'arrachement suffisant, la coiffe étant fixée sur l'orifice d'accès.

    CONTAINER FOR THE CONTROLLED ADMINISTRATION OF A BENEFICIAL AGENT
    6.
    发明公开
    CONTAINER FOR THE CONTROLLED ADMINISTRATION OF A BENEFICIAL AGENT 失效
    资金的控输注坦克舒缓。

    公开(公告)号：EP0586638A1

    公开(公告)日：1994-03-16

    申请号：EP93905008.0

    申请日：1993-02-09

    Applicant: BAXTER INTERNATIONAL INC.

    Inventor： BUTTON, Kathryn, M. ,  JEPSON, Steven, C. ,  LAL, Birendra, K. ,  REITZ, Douglas, W. ,  RICHARDSON, James ,  ROLLINS, Richard, A. ,  SOLTYS, Paul, J. ,  DUDAR, Thomas, E.

    IPC: A61M39 ,  A61M5 ,  A61M37

    CPC classification number: A61M5/1409

    Abstract: Récipient (30) destiné à contenir un agent bénéfique (66) pouvant être couplé de manière détachable à une structure (12) définissant un chemin d'écoulement de fluide. Le récipient (30) comprend un corps (32) définissant des première (56) et seconde (58) zones intérieures séparées par une paroi (60) aboutissant au niveau d'une ouverture (62) assurant une communication fluide entre les première (56) et seconde (58) zones intérieures. Une cannule (34) s'étendant à partir du corps (32) est reçue de façon amovible dans la structure (12) définissant le chemin du fluide. La cannule (34) présente un orifice d'admission (44) ainsi qu'un chemin (36) d'écoulement de fluide d'admission, et un orifice de sortie (54) ainsi qu'un chemin (37) d'écoulement de fluide de sortie. Le chemin (36) d'écoulement de fluide d'admission en communication fluide avec la première zone intérieure (56) et le chemin (37) d'écoulement de fluide de sortie étant en communication fluide avec la seconde zone intérieure (58). La seconde zone intérieure (58) contenant l'agent bénéfique solide (66) permet à du fluide s'écoulant dans le chemin d'écoulement de fluide d'admission de passer par au moins une partie de l'agent bénéfique (66).

    DRUG DELIVERY SYSTEM
    8.
    发明公开
    DRUG DELIVERY SYSTEM 失效
    供应系统CHINESE。

    公开(公告)号：EP0662851A1

    公开(公告)日：1995-07-19

    申请号：EP94921168.0

    申请日：1994-04-08

    Applicant: BAXTER INTERNATIONAL INC.

    Inventor： FOWLES, Thomas, A. ,  ROLLINS, Richard, A. ,  HOEKWATER, Mark, A.

    IPC: A61M39 ,  A61J1 ,  A61M5

    CPC classification number: A61J1/2089 ,  A61J1/201 ,  A61J1/2013 ,  A61J1/2065 ,  A61M5/1409

    Abstract: An improved drug delivery system and method for reconstituting drugs. The system allows the delivery of a medicament from a drug vial (40) directly into an intravenous line to a patient. The system provides a method and apparatus that insures that the drug vial is properly pierced and the vial is locked into an activated position when it is desired to use same. To this end, a vial retaining member (50) for coupling the vial to a cartridge (12) including a cannula (22) is provided. The retaining member includes a cannula centering member (64) extending from an end thereof.

    CONTAINER FOR THE CONTROLLED ADMINISTRATION OF A BENEFICIAL AGENT
    10.
    发明授权
    CONTAINER FOR THE CONTROLLED ADMINISTRATION OF A BENEFICIAL AGENT 失效
    罐车舒缓介质的受控的给药

    公开(公告)号：EP0586638B1

    公开(公告)日：1996-09-25

    申请号：EP93905008.4

    申请日：1993-02-09

    Applicant: BAXTER INTERNATIONAL INC.

    Inventor： BUTTON, Kathryn, M. ,  JEPSON, Steven, C. ,  LAL, Birendra, K. ,  REITZ, Douglas, W. ,  RICHARDSON, James ,  ROLLINS, Richard, A. ,  SOLTYS, Paul, J. ,  DUDAR, Thomas, E.

    IPC: A61M37/00 ,  A61M31/00 ,  A61M5/14

    CPC classification number: A61M5/1409

    Abstract: A container (30) for housing a beneficial agent (66) that can be removably coupled to a structure (12) defining a fluid flow path. The container (30) comprises a body (32) defining a first (56) and second (58) interior area separated by a wall (60) that terminates at an opening (62) providing fluid communication between the first (56) and second (58) interior area. A cannula (34) is provided that extends from the body (32) for being removably received by the structure (12) defining the fluid path. The cannula (34) including an inlet opening (44) and inlet fluid flow path (36) and an outlet opening (54) and outlet fluid flow path (37). The inlet fluid flow path (36) being in fluid communication with the first interior area (56), and the outlet fluid flow path (37) being in fluid communication with the second interior area (58). The second interior area (58) housing the solid beneficial agent (66) and allows fluid that flows through the inlet fluid flow path to pass by at least a portion of the beneficial agent (66).

Patent Agency Ranking